Therapeutic potential of a synthetic dual JAK1/TYK2 inhibitor in inflammatory bowel disease.

导出 LinkOut

翻译打印收藏纠错

第一作者： Xue,Cui

第一单位： Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.

作者： Xue,Cui ^[1] ; Yaxin,Teng ^[1] ; Yiguo,Hu ^[2] ; Qingqing,Li ^[3] ; Heying,Pei ^[4] ; Zhuang,Yang ^[5]

作者单位： Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. ^[1] Department of Thyroid Surgery, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: huyiguo@scu.edu.cn. ^[2] Innovation Center of Nursing Research and Nursing Key Laboratory of Sichuan Province, West China Hospital, Sichuan University/West China School of Nursing, Sichuan University, China. ^[3] Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: phy_05@163.com. ^[4] Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China. Electronic address: yangzhuang@scu.edu.com. ^[5]

关键词 Dual inhibitor Inflammatory bowel disease JAK1 TYK2

主题词小鼠(Mice);动物(Animals);蛋白激酶抑制剂(Protein Kinase Inhibitors);Janus激酶1(Janus Kinase 1);炎性肠疾病(Inflammatory Bowel Diseases);细胞因子类(Cytokines);白细胞介素12(Interleukin-12)

DOI 10.1016/j.intimp.2023.111238

PMID 37988912

发布时间 2024-02-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交